美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
50090-3226-0	50090-3226	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20171030	N/A	ANDA	ANDA065381	A-S Medication Solutions	CEFPROZIL	250 mg/5mL	50 mL in 1 BOTTLE (50090-3226-0)
65862-100-01	65862-100	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	Aurobindo Pharma Limited	CEFPROZIL	250 mg/5mL	100 mL in 1 BOTTLE (65862-100-01)
65862-100-50	65862-100	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	Aurobindo Pharma Limited	CEFPROZIL	250 mg/5mL	50 mL in 1 BOTTLE (65862-100-50)
65862-100-75	65862-100	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	Aurobindo Pharma Limited	CEFPROZIL	250 mg/5mL	75 mL in 1 BOTTLE (65862-100-75)
65862-099-01	65862-099	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	Aurobindo Pharma Limited	CEFPROZIL	125 mg/5mL	100 mL in 1 BOTTLE (65862-099-01)
65862-099-50	65862-099	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	Aurobindo Pharma Limited	CEFPROZIL	125 mg/5mL	50 mL in 1 BOTTLE (65862-099-50)
65862-099-75	65862-099	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	Aurobindo Pharma Limited	CEFPROZIL	125 mg/5mL	75 mL in 1 BOTTLE (65862-099-75)
16714-397-01	16714-397	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	NorthStar Rx LLC	CEFPROZIL	250 mg/5mL	50 mL in 1 BOTTLE (16714-397-01)
16714-397-02	16714-397	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	NorthStar Rx LLC	CEFPROZIL	250 mg/5mL	75 mL in 1 BOTTLE (16714-397-02)
16714-397-03	16714-397	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	NorthStar Rx LLC	CEFPROZIL	250 mg/5mL	100 mL in 1 BOTTLE (16714-397-03)
57237-035-01	57237-035	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	Rising Pharma Holdings, Inc.	CEFPROZIL	250 mg/5mL	100 mL in 1 BOTTLE (57237-035-01)
57237-035-50	57237-035	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	Rising Pharma Holdings, Inc.	CEFPROZIL	250 mg/5mL	50 mL in 1 BOTTLE (57237-035-50)
57237-035-75	57237-035	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	Rising Pharma Holdings, Inc.	CEFPROZIL	250 mg/5mL	75 mL in 1 BOTTLE (57237-035-75)
16714-396-02	16714-396	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	NorthStar Rx LLC	CEFPROZIL	125 mg/5mL	75 mL in 1 BOTTLE (16714-396-02)
16714-396-03	16714-396	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	NorthStar Rx LLC	CEFPROZIL	125 mg/5mL	100 mL in 1 BOTTLE (16714-396-03)
57237-034-01	57237-034	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	Rising Pharma Holdings, Inc.	CEFPROZIL	125 mg/5mL	100 mL in 1 BOTTLE (57237-034-01)
57237-034-50	57237-034	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	Rising Pharma Holdings, Inc.	CEFPROZIL	125 mg/5mL	50 mL in 1 BOTTLE (57237-034-50)
57237-034-75	57237-034	HUMAN PRESCRIPTION DRUG	Cefprozil	Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130	N/A	ANDA	ANDA065381	Rising Pharma Holdings, Inc.	CEFPROZIL	125 mg/5mL	75 mL in 1 BOTTLE (57237-034-75)